+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Glucagon Like Peptide 1 Agonist"

Type 2 Diabetes Mellitus Treatment Market - Global Strategic Business Report - Product Thumbnail Image

Type 2 Diabetes Mellitus Treatment Market - Global Strategic Business Report

  • Report
  • May 2026
  • 381 Pages
  • Global
From
Inadequately Controlled Type-II Diabetes Treatment Market Report 2026 - Product Thumbnail Image

Inadequately Controlled Type-II Diabetes Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Diabetic Peripheral Neuropathy - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetic Peripheral Neuropathy - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Diabetes - Pipeline Insight, 2026 - Product Thumbnail Image

Diabetes - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 450 Pages
  • Global
From
Type 2 Diabetes - Pipeline Insight, 2026 - Product Thumbnail Image

Type 2 Diabetes - Pipeline Insight, 2026

  • Drug Pipelines
  • April 2026
  • 280 Pages
  • Global
From
Hypoglycemia - Pipeline Insight, 2026 - Product Thumbnail Image

Hypoglycemia - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Prediabetes - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Prediabetes - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • December 2025
  • 200 Pages
  • Global
From
Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Diabetes Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 180 Pages
  • Global
From
Antidiabetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031 - Product Thumbnail Image

Antidiabetics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

  • Report
  • January 2026
  • 181 Pages
  • Global
From
Oral Anti-Diabetic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

Oral Anti-Diabetic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • May 2025
  • 183 Pages
  • Global
From
Diabetic Hypoglycemia Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Diabetic Hypoglycemia Epidemiology Forecast 2025-2034

  • Report
  • March 2026
  • 150 Pages
  • Global
From
Insulin Resistance Market Size and Share Outlook Report: Forecast Trends and Growth Analysis (2025-2034) - Product Thumbnail Image

Insulin Resistance Market Size and Share Outlook Report: Forecast Trends and Growth Analysis (2025-2034)

  • Report
  • March 2026
  • 400 Pages
  • Global
From
Type 2 Diabetes Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Type 2 Diabetes Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Severe Hypertriglyceridemia Pipeline Analysis Report 2025 - Product Thumbnail Image

Severe Hypertriglyceridemia Pipeline Analysis Report 2025

  • Report
  • June 2025
  • 200 Pages
  • Global
From
Hypoglycemia Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Hypoglycemia Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
Prediabetes Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Prediabetes Epidemiology Forecast 2025-2034

  • Report
  • June 2025
  • 150 Pages
  • Global
From
Type 2 Diabetes Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034) - Product Thumbnail Image

Type 2 Diabetes Market Size and Share Outlook - Forecast Trends and Growth Analysis Report (2025-2034)

  • Report
  • June 2025
  • 400 Pages
  • Global
From
Insulin - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Thumbnail Image

Insulin - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • January 2026
  • 130 Pages
  • Global
From
Non-Insulin Diabetes Therapeutics Market 2026-2030 - Product Thumbnail Image

Non-Insulin Diabetes Therapeutics Market 2026-2030

  • Report
  • January 2026
  • 286 Pages
  • Global
From
Peptide Based Metabolic Disorder Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Thumbnail Image

Peptide Based Metabolic Disorder Therapeutic Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • December 2025
  • 150 Pages
  • Global
From
Loading Indicator

The Glucagon Like Peptide 1 Agonist (GLP-1) market is a subset of the larger diabetes drugs market. GLP-1 agonists are a class of drugs used to treat type 2 diabetes, and are designed to mimic the effects of the hormone glucagon-like peptide-1 (GLP-1). GLP-1 agonists work by stimulating the release of insulin, reducing the amount of glucose in the blood, and slowing the rate of gastric emptying. GLP-1 agonists are typically administered via injection, and are used in combination with other diabetes medications. The GLP-1 agonist market is highly competitive, with a number of major pharmaceutical companies offering products. These include Novo Nordisk, Eli Lilly, Sanofi, AstraZeneca, and Boehringer Ingelheim. Show Less Read more